Top Markets
Coin of the day
NAYA Biosciences, Inc. NAYA Biosciences, Inc.

NAYA Biosciences, Inc.

NAYA
Rank in Stocks #33843
INVO Bioscience operates as a medical device company, focusing on the... INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.
Share Price
$1.78
Last synced: 2025-05-22
Market Cap
$6.77M
Change (1 day)
-9.18%
Change (1 year)
0.00%
Country
US
Trade NAYA Biosciences, Inc. (NAYA)

Category

P/E ratio for NAYA Biosciences, Inc. (NAYA)
P/E ratio as of August 2026 TTM: -0.07
According to NAYA Biosciences, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.07. At the end of 2023 the company had a P/E ratio of -5.99.
P/E ratio history for NAYA Biosciences, Inc. from 2006 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -0.07 -77.91%
2024 -0.33 -94.47%
2023 -5.99 -73.55%
2022 -22.64 -91.13%
2021 -255.37 168.76%
2020 -95.02 -87.23%
2019 -743.80 -22.97%
2018 -965.58 -35.49%
2017 -1.50K 35.99%
2016 -1.10K 26.35%
2015 -871.07 9.62%
2010 -794.63 526.60%
2009 -126.82 -88.76%
2008 -1.13K 3,543.85%
2007 -30.96 -99.97%
2006 -95.96K 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
35.77 -49,173.94%
US
34.86 -47,922.09%
US
21.39 -29,438.55%
IE
20.90 -28,768.31%
US
52.64 -72,313.58%
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.